Crossmark

Integrative proteomic analysis reveals the potential diagnostic marker and drug target for the Type‐2 diabetes mellitus

Published Online: 2025-01-22

Authors

Jia, Zhen

Jiang, Ning

Lin, Lin

Li, Bing

Liang, Xuewei https://orcid.org/0009-0006-5975-4327
License Information

Text and Data Mining valid from 2025-01-22

Version of Record valid from 2025-01-22
More Information

Article History

Received: 22 August 2024

Accepted: 5 January 2025

First Online: 22 January 2025

Declarations

:

: This study was approved by the AdventHealth Translational Research Institute Institutional Review Board (IRBNet# 238153; 13 July 2010) [], and King Abdullah University Hospital (KAUH) Institutional Review Board (IRB) (Ref.:9/123/2019) []. A written informed consent according to the Declaration of Helsinki and institutional approval was obtained from all participants involved in this study.

: No animals were used as part of this study. This research was conducted on humans following the Helsinki Declaration.

: The authors declare that they have no competing interests.

Document is current